Results 21-40 of 89 for drugs speaker:Pearse Doherty

Joint Oireachtas Committee on Finance, Public Expenditure and Reform, and Taoiseach: Update on Insurance Matters and Implementation of the Report on the Cost of Motor Insurance: Discussion (29 May 2018)

Pearse Doherty: ...intention that not only would legislation on access to terminations of pregnancies pass the Houses but also that he hoped legislation on the clinical directions and registration or licensing of the drugs required for terminations would be concluded by December. Will it be possible to have the national claims information database up and running by the end of the year or is it more likely...

Written Answers — Department of Health: Medicinal Products Availability (22 May 2018)

Pearse Doherty: 387. To ask the Minister for Health if a decision has been made to make the drug sapropterin available to patients (details supplied); and if he will make a statement on the matter. [22277/18]

Joint Oireachtas Committee on Finance, Public Expenditure and Reform, and Taoiseach: State Claims Agency: Discussion (8 May 2018)

Pearse Doherty: ...has value in itself? If these women knew this information earlier, it would not have changed their diagnosis of cervical cancer but it would have allowed them to look at other types of treatment, drugs or clinical trials. Those options were delayed. In three cases in which proceedings against the State are under way the options were not only delayed but those involved never had the...

Topical Issue Debate: Hospital Facilities (7 Feb 2018)

Pearse Doherty: ...Vimizim, which is for the treatment of Morquio A syndrome. I appreciate that this condition is a serious one and that the families of children diagnosed with this illness are extremely anxious to obtain any treatment which they believe will alleviate its symptoms. The HSE drugs group, which reviewed the effectiveness of the drug, did not consider the evidence for its clinical benefit to...

Written Answers — Department of Health: Medicinal Products Reimbursement (17 Oct 2017)

Pearse Doherty: 403. To ask the Minister for Health if the drug Kuvan sapropterin will be approved for reimbursement for those diagnosed with the genetic condition phenylketonuria; and if he will make a statement on the matter. [44017/17]

Written Answers — Department of Finance: Drugs Seizures (4 Apr 2017)

Pearse Doherty: 164. To ask the Minister for Finance the value of illegal drugs seized and destroyed respectively in each of the past five years; and if he will make a statement on the matter. [16156/17]

Joint Oireachtas Committee on Justice, Defence and Equality: Recent Controversies Concerning An Garda Síochána (30 Mar 2017)

Pearse Doherty: I thank Senator Conway. Deputies are being called to the Dáil for an imminent vote. As I have been saying for a number of years, the amount of controlled drugs that An Garda Síochána is holding is bizarre. I know the Tánaiste and Minister for Justice and Equality, Deputy Fitzgerald, has asked the Commissioner for a report on this. The most recent figures I have are...

Written Answers — Department of Transport, Tourism and Sport: Coast Guard Services (21 Mar 2017)

Pearse Doherty: ...training to advanced paramedic level or equivalent and to incorporate this training as part of the employees' professional development and, therefore, permitting them to administer life saving drugs, medicines and pain relief to persons; and if he will make a statement on the matter. [13658/17]

Written Answers — Department of Justice and Equality: Drugs Seizures (23 Feb 2017)

Pearse Doherty: 112. To ask the Minister for Justice and Equality the value of illegal drugs seized and destroyed, respectively, in each of the past five years; and if she will make a statement on the matter. [9505/17]

Written Answers — Department of Health: Medicinal Products Regulation (21 Feb 2017)

Pearse Doherty: ...the details of the progress made to provide for the reimbursement of the cannabis-based medical product Sativex for the treatment of symptoms of sufferers of multiple sclerosis, thus making the drug accessible to persons; and if he will make a statement on the matter. [8735/17]

Consumer Insurance Contracts Bill 2017: Second Stage [Private Members] (9 Feb 2017)

Pearse Doherty: ..., Hanna J. dismissed the appellant's appeal on the basis that the correct test of materiality had been applied by the FSO and that the insurance contract in question had converted the non-disclosure into a "basis of contract" warranty. Hanna J. added that it was "regrettable" that the appellant who stands wholly innocent of the drugs charges which were levelled against him, must find...

Written Answers — Department of Health: Drugs Payment Scheme Coverage (26 Oct 2016)

Pearse Doherty: 132. To ask the Minister for Health when he will make a decision on an application to include the drug Kuvan sapropterin in the drug reimbursement programme; and if he will make a statement on the matter. [32254/16]

Written Answers — Department of Health: Drug Treatment Programmes (16 Sep 2016)

Pearse Doherty: 1185. To ask the Minister for Health the total number of residential and inpatient detoxification beds available for the purpose of treatment for drug and alcohol misuse in the State; the number of such beds which are available within each local health office area with respect to all LHOs in tabular form; and if he will make a statement on the matter. [25196/16]

Written Answers — Department of Health: Drug Treatment Programmes (16 Sep 2016)

Pearse Doherty: 1186. To ask the Minister for Health the patient waiting times, per facility, in relation to those awaiting access to residential and inpatient detoxification beds for the purpose of treatment for drug and alcohol misuse, and who have been waiting for six, nine, 12, 15 months and more than 15 months in tabular form; and if he will make a statement on the matter. [25197/16]

Written Answers — Department of Health: Drugs Payment Scheme Coverage (17 May 2016)

Pearse Doherty: 760. To ask the Minister for Health when he will make a decision on an application to include the drug kuvan sapropterin in the drug reimbursement programme; and if he will make a statement on the matter. [10033/16]

Written Answers — Department of Health: Magdalen Laundries Data (17 Dec 2015)

Pearse Doherty: ...ask the Minister for Health the cost of broadening the scheme for women living abroad who suffered in the Magdalen laundries, who are now entitled to free general practitioner services, prescribed drugs, surgical appliances, nursing and home help services, dental, ophthalmic and aural services, counselling, chiropody and physiotherapy, upon their return to Ireland, to include all returning...

Written Answers — Department of Health: Drugs Payment Scheme Coverage (2 Dec 2015)

Pearse Doherty: 137. To ask the Minister for Health the status of the application to include the drug Kuvan Sapropterin in the drug re-imbursement programme; and if he will make a statement on the matter. [43172/15]

Written Answers — Department of Health: Medicinal Products Prices (17 Nov 2015)

Pearse Doherty: .... To ask the Minister for Health the timeframe for the processing of the new application submitted by a manufacturer (details supplied) for the pricing and reimbursement of Kuvan, or sapropterin, a drug used to treat persons with phenylketonuria; and if he will make a statement on the matter. [40427/15]

Financial Resolutions 2016 - Budget Statement 2016 (13 Oct 2015)

Pearse Doherty: ...of its first three budgets. Is it any wonder there is a deepening crisis right across the health system? The Government targeted mental health, children’s services and disability services, increased the threshold for the drug payment scheme by 20%, increased prescription charges for the least well off, cut front-line posts by up to 10% and slashed the regional drugs-related...

Written Answers — Department of Health: Medicinal Products Supply (13 Oct 2015)

Pearse Doherty: 285. To ask the Minister for Health his plans for the drug Sapropterin, also known as Kuvan, to be added to the drug reimbursement programme. [35478/15]